Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
Volume: 5, Issue: 11, Pages: 864 - 876
Published: Sep 14, 2017
Paper Details
Title
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
Published Date
Sep 14, 2017
Volume
5
Issue
11
Pages
864 - 876
Notes
History